A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis

Francisco Javier Carod-Artala Neurology Department, Raigmore Hospital, NHS Highlands, Inverness, UKView further author information

Peyman Adjamianb Medical Affairs Europe and International, GW Pharmaceuticals LTD, part of Jazz Pharmaceuticals, Cambridge, UKView further author information

Carlos Vila Silvánc Global Medical Affairs, Almirall SA, Barcelona, SpainView further author information

Makarand Bagulb Medical Affairs Europe and International, GW Pharmaceuticals LTD, part of Jazz Pharmaceuticals, Cambridge, UKView further author information

Claudio Gasperinid Department of Neurosciences, S Camillo Forlanini Hospital of Rome, ItalyCorrespondence[email protected]
View further author information

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.